The purpose of this study is to evaluate effectiveness and safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice

Inclusion Criteria:

• Age 19 and more
• Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent
• Agreed with written informed consent form

Exclusion Criteria:

• Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent and other drug eluting stent at the same time
• Life expectancy of 1year and under
• Cardiac shock

patients with XIENCE Xpedition or Alpine or Sierra stent

This is not a publicly funded trial.